Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$2.6B |
| 2 |
Abbott
ABT
|
+$1.29B |
| 3 |
Home Depot
HD
|
+$1.03B |
| 4 |
Devon Energy
DVN
|
+$888M |
| 5 |
PepsiCo
PEP
|
+$880M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$1.6B |
| 2 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
+$1.5B |
| 3 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$1.34B |
| 4 |
Texas Instruments
TXN
|
+$1.32B |
| 5 |
CTRA
Coterra Energy
CTRA
|
+$789M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.11% |
| 2 | Financials | 10.61% |
| 3 | Healthcare | 10.33% |
| 4 | Miscellaneous | 9.93% |
| 5 | Industrials | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
Freshworks
FRSH
$3.11B
| $18.2M | ﹤0.01% |
1,799,101
+55,754
| +3% | +$496K |
|
1877
Enact Holdings
ACT
$6.81B
| $18.2M | ﹤0.01% |
398,297
+6,198
| +2% | +$265K |
|
1878
Surgery Partners
SGRY
$1.85B
| $18.2M | ﹤0.01% |
1,081,600
-25,650
| -2% | -$360K |
|
1879
Simply Good Foods
SMPL
$919M
| $18.2M | ﹤0.01% |
1,367,110
+155,231
| +13% | +$1.92M |
|
1880
Equinox Gold
EQX
$15B
| $18.1M | ﹤0.01% |
+1,862,555
| New | +$24M |
|
1881
Douglas Dynamics
PLOW
$947M
| $18.1M | ﹤0.01% |
335,740
+14,165
| +4% | +$653K |
|
1882
HCI Group
HCI
$2.31B
| $18.1M | ﹤0.01% |
103,081
+2,870
| +3% | +$452K |
|
1883
Braze
BRZE
$2.67B
| $18M | ﹤0.01% |
831,016
+36,448
| +5% | +$812K |
|
1884
Donnelley Financial Solutions
DFIN
$1.2B
| $18M | ﹤0.01% |
429,256
-3,662
| -0.8% | -$160K |
|
1885
Trevi Therapeutics
TRVI
$2.37B
| $18M | ﹤0.01% |
965,402
+124,830
| +15% | +$1.82M |
|
1886
QuidelOrtho
QDEL
$867M
| $17.8M | ﹤0.01% |
1,018,104
+188,045
| +23% | +$2.48M |
|
1887
Sinclair Inc
SBGI
$980M
| $17.8M | ﹤0.01% |
1,251,051
-409,877
| -25% | -$5.9M |
|
1888
MarineMax
HZO
$1.15B
| $17.8M | ﹤0.01% |
486,271
-88,395
| -15% | -$2.84M |
|
1889
Syndax Pharmaceuticals
SNDX
$1.77B
| $17.8M | ﹤0.01% |
814,303
+99,150
| +14% | +$2.06M |
|
1890
Empire State Realty Trust
ESRT
$734M
| $17.7M | ﹤0.01% |
3,278,870
+5,397
| +0.2% | +$29.4K |
|
1891
J&J Snack Foods
JJSF
$1.54B
| $17.7M | ﹤0.01% |
241,119
+16,093
| +7% | +$1.25M |
|
1892
NeoGenomics
NEO
$2.27B
| $17.7M | ﹤0.01% |
1,212,407
+24,679
| +2% | +$238K |
|
1893
Lindsay Corp
LNN
$1.23B
| $17.6M | ﹤0.01% |
142,401
+6,085
| +4% | +$680K |
|
1894
Sarepta Therapeutics
SRPT
$2.33B
| $17.6M | ﹤0.01% |
980,321
+189,192
| +24% | +$3.58M |
|
1895
Collegium Pharmaceutical
COLL
$760M
| $17.6M | ﹤0.01% |
486,601
-8,426
| -2% | -$288K |
|
1896
Stock Yards Bancorp
SYBT
$2.41B
| $17.6M | ﹤0.01% |
229,815
+5,335
| +2% | +$383K |
|
1897
BP
BP
$118B
| $17.5M | ﹤0.01% |
474,713
+64,503
| +16% | +$2.83M |
|
1898
Pacira BioSciences
PCRX
$1.03B
| $17.5M | ﹤0.01% |
690,786
-41,256
| -6% | -$975K |
|
1899
ADMA Biologics
ADMA
$2.12B
| $17.5M | ﹤0.01% |
2,092,594
-3,178
| -0.2% | -$29K |
|
1900
Comstock Resources
CRK
$4.37B
| $17.4M | ﹤0.01% |
1,163,099
+71,252
| +7% | +$1.09M |
|
Similar funds
Charles Schwab's Q2 2026 Portfolio in Review
As of Q2 2026, Charles Schwab held 3,591 positions worth $751B, up 15% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Charles Schwab's Q2 2026 filing shows 136 new, 2,145 increased, 1,132 reduced and 153 closed positions. Its largest new stake was Honeywell Aerospace: 2,031,187 shares worth $449M. The largest sale was Qualcomm, an estimated $1.6B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2026 buy was Honeywell Aerospace: 2,031,187 shares worth $449M.
- Charles Schwab added most to Schwab US Large-Cap Growth ETF in Q2 2026, an estimated $2.6B increase.
- Charles Schwab's biggest Q2 2026 reduction was Qualcomm, cutting an estimated $1.6B.
- Charles Schwab fully exited Coterra Energy in Q2 2026, selling an estimated $789M.
- Charles Schwab's ten largest holdings make up 22% of its $751B portfolio in Q2 2026.
- Charles Schwab opened 136 new positions and closed 153 in Q2 2026.
- Charles Schwab's portfolio value rose 15% quarter-over-quarter to $751B.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.